🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#Astro24 session on liver metastasis with Percy Lee MD and Dr Singh from City of Hope Surgery

Way to go Kristin Higgins!!! Plenary session talk on results of NRG Oncology Lu005 study of concurrent atezo in LS-SCLC. #ASTRO24 City of Hope City of Hope - Department of Radiation Oncology

Congratulations to our own Dr Wong on his Phase II trial of 20 Gy TMLI with Cy and VP16. Truly a paradigm shift for these patients. Excited to continue advancing this treatment option for patients with leukemia. City of Hope - Department of Radiation Oncology #ASTRO24

Congrats Colton Ladbury, MD !

Congrats Lilie Lin !!!

Podcast on substantial LVSI in setting of nodal assessment podcasts.apple.com/us/podcast/lis… DrKamrava Scott Glaser Andrew Keller Ann Klopp Emma Fields, MD #gynsm

Way to go Heather McGee, MD PhD !

Way to go Colton Ladbury, MD!!! We City of Hope - Department of Radiation Oncology are so happy to have you providing such great care City of Hope!

Time’s running out! The deadline to vote in the U.S. News & World Report #BestHospitals survey is March 23. Join Terry Williams and vote for City of Hope! Learn more: cityofhope.org/top5

We are excited to have you join the phenomenal City of Hope - Department of Radiation Oncology team Eemon and Tomiwa! Congratulations! 🎉🥳 Another highly successful match year for us! #radonc #MatchDay Scott Glaser City of Hope City of Hope Surgery City of Hope Department of Medical Oncology City of Hope | Orange County

Congrats Jeff! Very impressive and inspiring!

Congrats Yun Rose Li !

So cool to see you improve cancer care around the world!

Elective para-aortic RT + 24 months ADT shows promising results in pN1 prostate cancer! In the PART trial (n=96), 5y clinical RFS reached 91% in the adjuvant setting vs 63% salvage (p=0.029) with acceptable toxicity. Early intervention matters. #ESTRO2025 #RadOnc #ProstateCancer

Danish data with longer follow up shows no difference in lymphedema or LRR with RNI hypofractionation Icro Meattini Erin Gillespie, MD MPH Scott Glaser Andrew Keller #estro2025

PLATO ACT 4 results for dose de-escalation in early-stage anal cancer are out! Prof Sebag-Montefiore presents on the plenary stage at #ESTRO24 3-year locoregional failure 16.4% for standard dose IMRT vs 12.4% reduced dose IMRT Reduced dose IMRT is safe & effective! #radonc

Reassuring toxicity data from PCS IX trial after hypofractionated (5*5 Gy) pelvic & prostate #radiotherapy priori to #brachytherapy boost for #prostatecancer. #ESTRO25

Isotoxic FLAME shows 15% BCR difference with 10 years follow up with significant difference in local and regional recurrence #ESTRO2025 Amar Kishan

Best #ESTRO2025 abstract for EMBRACE2 showing excellent locoregional control and significantly reduced morbidity compared to embrace 1 with tighter dose constraints with higher use of hybrid applicator ( new standard ) DrKamrava Scott Glaser Andrew Keller American Brachy

STORM-PEACE V trial reported by Thomas Zilli #ESTRO25 Pelvic ENI superior to MDT for pelvic relapses after local Tx for #prostate cancer (6mo ADT each) Improves Biochemical PFS Locoregional PFS MFS ADT free survival Tox NS ENI clear SOC Online The Lancet Oncology Cc Piet Ost